Could targeting immunometabolism be a way to control the burden of COVID-19 infection?

Berber E., Sumbria D., Rouse B. T.

Microbes and infection, cilt.23, 2021 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.micinf.2021.104780
  • Dergi Adı: Microbes and infection
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Environment Index, MEDLINE, Veterinary Science Database
  • Anahtar Kelimeler: SARS-Cov-2, Covid-19, Immunometabolism, Metabolic disease, Nutrition, Anti-metabolite therapy, GUT MICROBIOTA, DIETARY FIBER, GLUCOSE, HYPERGLYCEMIA, SARS-COV-2, MICE, FAT
  • Erciyes Üniversitesi Adresli: Evet

Özet

This review portrays the metabolic consequences of Covid-19 infection at different stages of the clinical syndrome. It also describes how events can change when patients with metabolic problems are infected and the effects that diet and nutrition might play to influence the outcome of infection. We also discuss the types of maneuvers that could be used to reshape metabolic events and question if this approach could be a practical therapy used alone or in combination with other approaches to reduce the burden of Covid-19 infection. (c) 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.